Neogenomics (NEO) PT Raised to $16 at Benchmark

July 24, 2026 7:32 AM

Benchmark analyst Bruce Jackson raised the price target on Neogenomics (NASDAQ: NEO) to $16.00 (from $11.00) while maintaining a Buy rating.

No results found